TGFB1 and Hepatic fibrosis: At the inflammatory level, the therapeutic effect of SIL, CNPs, and SCNPs on CCl4-induced liver fibrosis was consistent with their ability to reduce the hepatic TGF-β1 production with the best effect in the rats treated with SCNPs.